Is soursop safe to eat, and does it fight cancer?

Soursop's phytochemistry is unusually rich. The fruit, leaves, seeds, and bark all contain acetogenins — a large class of compounds found only in the Annonaceae plant family — as well as alkaloids, flavonoids, and polyphenols¹.

Antioxidants and anti-inflammatory compounds: Soursop flesh and leaves demonstrate significant antioxidant activity, measured across multiple assays including DPPH, CUPRAC, and FRAP⁵. The flavonoids quercetin, kaempferol, and rutin are among the identified contributors. In cell and animal models, extracts reduce markers of oxidative stress and inflammation.

Anticancer research: Acetogenins are the most intensively studied compounds in soursop. In vitro (cell culture) studies have shown selective cytotoxicity against cancer cell lines — meaning they can kill cancer cells while sparing healthy ones to some degree¹. This mechanism involves inhibiting mitochondrial complex I in cancer cells, which preferentially use a different energy pathway than normal cells. These results have generated significant popular interest in soursop as an "anti-cancer" food. The critical limitation is that no human clinical trials have confirmed these effects in living people, and the doses used in cell studies are difficult to achieve through dietary consumption.

The Annonacin Problem

The same mitochondrial complex I inhibition that makes acetogenins cytotoxic to cancer cells in a dish also makes them neurotoxic in the brain.

Annonacin is the most abundant and well-studied acetogenin in soursop. It crosses the blood-brain barrier and accumulates in dopaminergic neurons — the same cells lost in Parkinson's disease. Rat studies showed that direct administration of annonacin caused nigral and striatal neurodegeneration resembling parkinsonism³. Cultured human mesencephalic neurons show the same pattern: annonacin impairs energy metabolism and kills dopamine-producing cells at physiologically relevant concentrations⁴.

The population-level concern emerged from the French Caribbean island of Guadeloupe, where rates of a Parkinson's-like condition called atypical parkinsonism were unusually high. A landmark case-control study published in The Lancet in 1999 found a strong association between regular consumption of soursop fruit, juice, and herbal teas made from soursop leaves and this neurological condition². The condition, now called Guadeloupean parkinsonism, is distinct from typical Parkinson's disease and does not respond to standard Parkinson's medications.

Practical implications:

• Occasional consumption of soursop fruit is unlikely to be harmful for most people
• Regular drinking of soursop leaf tea, concentrated supplements, or high-dose extracts is the higher-risk pattern
• Seeds contain the highest concentrations of acetogenins and should not be consumed
• People with a family history of Parkinson's disease or other movement disorders should exercise particular caution

See our organ meats page for other nutrient-dense foods without this safety caveat. For anti-inflammatory fruit options, see our pomegranate and acai berry pages.

Phytochemical Profile and Biological Activities

The 2015 comprehensive review by Moghadamtousi et al. in International Journal of Molecular Sciences (PMID 26184167) synthesized evidence from over 60 studies on Annona muricata. The review identified more than 100 annonaceous acetogenins isolated from soursop, with annonacin, annohexocin, and muricin series compounds among the most thoroughly characterized. Biological activities confirmed in the review include cytotoxic, antiparasitic, antimicrobial, anti-inflammatory, and antidiabetic effects, predominantly demonstrated in cell cultures and animal models. The review explicitly noted the gap between in vitro potency and in vivo human evidence.

The 2024 antioxidant study by Hartati et al. (Biomedical Reports, PMID 39301565) used response surface methodology to optimize leaf extraction conditions. Optimized extracts showed IC₅₀ values of 57.3 µg/mL (DPPH), 103.8 µg/mL (CUPRAC), and 0.43 mM FeSO₄ equivalent (FRAP). These are moderate antioxidant values comparable to many common vegetables, confirming that soursop leaves contain meaningful antioxidant compounds but are not dramatically superior to more extensively studied botanicals.

Neurotoxicity Evidence

Animal model (2004): Champy et al. in the Journal of Neurochemistry (PMID 14675150) demonstrated that intraperitoneal annonacin administration in rats produced dose-dependent neurodegeneration in the substantia nigra and striatum within 28 days. Tau protein accumulation was observed, consistent with tauopathy — the pathological signature of Guadeloupean parkinsonism rather than classical Parkinson's. Calculated daily intake from moderate soursop consumption was estimated to be equivalent to the neurotoxic doses used in rat models, scaled for body weight.

Cellular mechanism (2003): Lannuzel et al. in Neuroscience (PMID 14521988) showed that annonacin at nanomolar concentrations selectively reduced ATP production in dopaminergic neurons, triggering apoptosis. The effect was blocked by complex I bypass agents, confirming mitochondrial complex I inhibition as the mechanism. Notably, the neurons most sensitive were those of the mesencephalon — the region damaged in Parkinson's disease.

Epidemiological link (1999): The Caparros-Lefebvre and Elbaz Lancet study (PMID 10440304) was a case-control study conducted across Guadeloupe involving 87 consecutive patients with atypical parkinsonism and 87 matched controls. Consumption of Annona muricata (soursop, locally called corossol) and related Annona species was assessed via dietary questionnaire. The odds ratio for parkinsonism among those who regularly consumed soursop fruits or leaf tea was significantly elevated (OR approximately 11 for the highest consumption tertile). The authors estimated that regular soursop consumers ingested annonacin in quantities comparable to those producing neurodegeneration in animal experiments. This study was the catalyst for the subsequent mechanistic investigations.

Limitations and Evidence Gaps

The anti-cancer excitement around soursop is almost entirely based on in vitro data. Cell culture studies cannot predict human pharmacokinetics — the concentrations of acetogenins needed to kill cancer cells in a dish are not achievable through food consumption, and oral bioavailability of large acetogenin molecules is poorly characterized. No human clinical trials exist for soursop as a cancer treatment.

The neurotoxicity evidence, by contrast, is coherent across epidemiology, animal models, and cellular mechanisms — a stronger foundation for caution. Regulatory agencies in several European countries have issued warnings about soursop leaf tea and supplements specifically because of this evidence base.

The fruit flesh contains lower acetogenin concentrations than leaves or seeds, and occasional fruit consumption in the context of a varied diet represents meaningfully lower risk than regular supplement or tea use.